該当箇所へ

ケーススタディ:規制された製造環境における治療用オリゴヌクレオチドの品質管理の自動化

In this Case Study Dr Juliet Padden and Dr Heiner Apeler describe how Bayer Pharmaceuticals worked together with Genedata to develop a fully automated data processing, analysis, and reporting workflow for QC of therapeutic oligonucleotides that addressed and overcame the following key challenges:

  • Implementing an end-to-end software solution for oligonucleotide analysis 
  • Deploying the solution into a GMP environment 
  • Streamlining and automating the entire process 
  • Meeting a range of new up- and downstream analytical demands